These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34263540)

  • 1. Efficacy of long-acting injectable versus oral antipsychotic drugs in early psychosis: A systematic review and meta-analysis.
    Lian L; Kim DD; Procyshyn RM; Fredrikson DH; Cázares D; Honer WG; Barr AM
    Early Interv Psychiatry; 2022 Jun; 16(6):589-599. PubMed ID: 34263540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of long-acting injectable
    Vita G; Tavella A; Ostuzzi G; Tedeschi F; De Prisco M; Segarra R; Solmi M; Barbui C; Correll CU
    Ther Adv Psychopharmacol; 2024; 14():20451253241257062. PubMed ID: 38831918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.
    Kishimoto T; Robenzadeh A; Leucht C; Leucht S; Watanabe K; Mimura M; Borenstein M; Kane JM; Correll CU
    Schizophr Bull; 2014 Jan; 40(1):192-213. PubMed ID: 23256986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia.
    Cai C; Kozma C; Patel C; Benson C; Yunusa I; Zhao P; Reeder G; Narasimhan M; Bank RL
    J Manag Care Spec Pharm; 2024 Jun; 30(6):549-559. PubMed ID: 38824623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics.
    Misawa F; Kishimoto T; Hagi K; Kane JM; Correll CU
    Schizophr Res; 2016 Oct; 176(2-3):220-230. PubMed ID: 27499361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.
    Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU
    Lancet Psychiatry; 2021 May; 8(5):387-404. PubMed ID: 33862018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016-March 2019.
    Peters L; Krogmann A; von Hardenberg L; Bödeker K; Nöhles VB; Correll CU
    Curr Psychiatry Rep; 2019 Nov; 21(12):124. PubMed ID: 31745659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
    Fang SC; Huang CY; Shao YJ
    J Clin Psychiatry; 2022 Jun; 83(4):. PubMed ID: 35649156
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of Neuroleptic Malignant Syndrome With Depot Versus Oral Antipsychotics: A Systematic Review and Pooled, Patient-Level Analysis of 662 Case Reports.
    Guinart D; Misawa F; Rubio JM; Pereira J; Sharma H; Schoretsanitis G; Kane JM; Correll CU
    J Clin Psychiatry; 2020 Nov; 82(1):. PubMed ID: 33238083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review.
    Lian L; Kim DD; Procyshyn RM; Cázares D; Honer WG; Barr AM
    PLoS One; 2022; 17(4):e0267808. PubMed ID: 35486616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting injectable antipsychotics: evidence of effectiveness and use.
    Manchanda R; Chue P; Malla A; Tibbo P; Roy MA; Williams R; Iyer S; Lutgens D; Banks N
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):5S-13S. PubMed ID: 23945067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies.
    Kishimoto T; Hagi K; Nitta M; Leucht S; Olfson M; Kane JM; Correll CU
    Schizophr Bull; 2018 Apr; 44(3):603-619. PubMed ID: 29868849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia.
    Huang CY; Fang SC; Shao YJ
    JAMA Netw Open; 2021 May; 4(5):e218810. PubMed ID: 33974056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.
    Verdoux H; Pambrun E; Tournier M; Bezin J; Pariente A
    Acta Psychiatr Scand; 2017 May; 135(5):429-438. PubMed ID: 28332704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturalistic study on the effectiveness of long-acting antipsychotics in an early intervention program for patients with recent-onset psychosis.
    Martín-Muñoz JC; Acuña MJ; Carrión-Mellado N; Blanco-Venzalá M; Mantrana-Ridruejo L; Rico-Villademoros F; Rosado-Tejero L; Utrera-Caballero E
    Early Interv Psychiatry; 2023 Apr; 17(4):378-384. PubMed ID: 35716056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies.
    Kishimoto T; Nitta M; Borenstein M; Kane JM; Correll CU
    J Clin Psychiatry; 2013 Oct; 74(10):957-65. PubMed ID: 24229745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Second Generation Long-acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary: An Update.
    Takács P; Kunovszki P; Timtschenko V; Fehér L; Balázs T; Hegyi R; Czobor P; Bitter I
    Schizophr Bull Open; 2022 Jan; 3(1):sgac013. PubMed ID: 39144770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics.
    Lin CH; Chan HY; Hsu CC; Chen FC
    J Affect Disord; 2021 Jan; 279():292-298. PubMed ID: 33096327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study.
    Rubio JM; Taipale H; Correll CU; Tanskanen A; Kane JM; Tiihonen J
    Psychol Med; 2020 Jun; 50(8):1356-1367. PubMed ID: 31190660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting injectable antipsychotics for the prevention of relapse in patients with recent-onset psychotic disorders: A systematic review and meta-analysis of randomized controlled trials.
    Kishi T; Oya K; Iwata N
    Psychiatry Res; 2016 Dec; 246():750-755. PubMed ID: 27863801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.